Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Dermira Inc (DERM)

Dermira Inc (DERM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Dermira Presents Data From Phase 2b Study of Lebrikizumab in Patients With Atopic Dermatitis at Fall Clinical Dermatology Conference

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with...

DERM : 5.69 (+4.21%)
Aclaris Divests Rhofade to EPI Health for $55M, Shares Up

Aclaris (ACRS) divests worldwide rights to its rosacea drug, Rhofade, to privately-held EPI Health as part of its restructuring program.

AGN : 172.50 (+0.92%)
DERM : 5.69 (+4.21%)
RIGL : 1.60 (-2.44%)
ACRS : 1.66 (+6.41%)
Shares of Aerie Pharmaceut Rank the Highest in Terms of Relative Performance in the Pharmaceuticals Industry (AERI , NKTR , DERM , SUPN , PRGO )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

AERI : 21.25 (+2.31%)
DERM : 5.69 (+4.21%)
NKTR : 17.77 (+1.31%)
Dermira Starts Lebrikizumab Dosing in Late-Stage Eczema Study

Dermira (DERM) starts a phase III program for evaluation of its monoclonal antibody candidate, lebrikizumab, in adolescents and adult patients with atopic dermatitis, the most common form of eczema.

LLY : 108.46 (+0.47%)
SNY : 46.50 (+1.66%)
REGN : 301.57 (+0.72%)
DERM : 5.69 (+4.21%)
Dermira to Present Data from Phase 2b Study of Lebrikizumab in Patients with Atopic Dermatitis at Fall Clinical Dermatology Conference

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with...

DERM : 5.69 (+4.21%)
Look for Shares of Dermira to Potentially Rebound after Yesterday's 1.40% Sell Off

Dermira (NASDAQ:DERM) traded in a range yesterday that spanned from a low of $5.61 to a high of $5.88. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of $5.63 on volume...

DERM : 5.69 (+4.21%)
Dermira Announces Initiation of Phase 3 Program Evaluating Lebrikizumab in Patients with Moderate-to-Severe Atopic Dermatitis

--- Topline results from the 16-week induction period expected in the first half of 2021

DERM : 5.69 (+4.21%)
Dermira Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with...

DERM : 5.69 (+4.21%)
Lannett Co Inc is Among the Companies in the Pharmaceuticals Industry with the Best Relative Performance (LCI , PCRX , DERM , BMY , HZNP )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

DERM : 5.69 (+4.21%)
LCI : 11.95 (+4.92%)
PCRX : 38.92 (-0.28%)
Dermira Shares Down 44.8% Since SmarTrend's Sell Call (DERM)

SmarTrend identified a Downtrend for Dermira (NASDAQ:DERM) on May 2nd, 2019 at $10.44. In approximately 5 months, Dermira has returned 44.83% as of today's recent price of $5.76.

DERM : 5.69 (+4.21%)
Intra-Cellular T has the Best Relative Performance in the Pharmaceuticals Industry (ITCI , LCI , DERM , JNJ , MDCO )

Below are the top five companies in the Pharmaceuticals industry as measured by relative performance. This analysis was compiled based on yesterday's trading activity as we search for stocks that have...

DERM : 5.69 (+4.21%)
ITCI : 8.50 (+1.19%)
LCI : 11.95 (+4.92%)
Dermira to Participate in the 2019 Cantor Global Healthcare Conference

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with...

DERM : 5.69 (+4.21%)
Look for Shares of Dermira to Potentially Rebound after Yesterday's 5.04% Sell Off

Dermira (NASDAQ:DERM) traded in a range yesterday that spanned from a low of $7.15 to a high of $7.60. Yesterday, the shares fell 5.0%, which took the trading range below the 3-day low of $7.51 on volume...

DERM : 5.69 (+4.21%)
Shares of DERM Down 20.7% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Dermira (NASDAQ:DERM) on May 2nd, 2019 at $10.44. In approximately 5 months, Dermira has returned 20.69% as of today's recent price of $8.28.

DERM : 5.69 (+4.21%)
Top 5 Companies in the Pharmaceuticals Industry with the Best Relative Performance (LCI , HZNP , DERM , RVNC , MDCO )

Here are the top 5 stocks in the Pharmaceuticals industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

DERM : 5.69 (+4.21%)
HZNP : 28.48 (-0.42%)
LCI : 11.95 (+4.92%)
Dermira Has Returned 14.7% Since SmarTrend Recommendation (DERM)

SmarTrend identified a Downtrend for Dermira (NASDAQ:DERM) on May 2nd, 2019 at $10.44. In approximately 4 months, Dermira has returned 14.66% as of today's recent price of $8.91.

DERM : 5.69 (+4.21%)
Relatively Good Performance Detected in Shares of Lannett Co Inc in the Pharmaceuticals Industry (LCI , PRGO , DERM , AERI , MYL )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

DERM : 5.69 (+4.21%)
LCI : 11.95 (+4.92%)
PRGO : 54.39 (+0.85%)
Dermira has the Best Relative Performance in the Pharmaceuticals Industry (DERM , LCI , PAHC , XENT , ITCI )

We looked at the Pharmaceuticals industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look...

DERM : 5.69 (+4.21%)
LCI : 11.95 (+4.92%)
PAHC : 21.44 (-0.19%)
Dermira Down 26.9% Since SmarTrend Downtrend Call (DERM)

SmarTrend identified a Downtrend for Dermira (NASDAQ:DERM) on May 2nd, 2019 at $10.44. In approximately 4 months, Dermira has returned 26.92% as of today's recent price of $7.63.

DERM : 5.69 (+4.21%)
Dermira to Participate in Upcoming Investor Conferences

Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with...

DERM : 5.69 (+4.21%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +4.89 , AIZ +0.49 , SBAC +7.10 , SO -0.03 , WELL +0.16
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar